Glioblastoma in the elderly (> 65 years of age) is associated with shorter overall survival
(OS) than in younger patients. Best practice recommendations for elderly patients, especially …

Purpose: Elderly patients make up a large percentage of the individuals newly diagnosed
with glioblastoma (gbm), but they face particular challenges in tolerating standard therapy …

Approximately half of all patients with glioblastoma are older than 65 years and nearly one-
quarter are older than 70 years, with a rising incidence of this disease in the elderly …

The incidence of glioblastoma (GBM) in the elderly population is slowly increasing in
Western countries. Current management includes surgery, radiation therapy (RT) and …

Background/purpose Optimal care for elderly patients with glioblastoma (GBM) remains in
question due to their exclusion from and underrepresentation in many clinical trials …

Managing elderly patients with glioblastoma presents a unique set of challenges, including
a scarcity of available data, which limits evidence-based recommendations. Nearly half of …

Background: Optimal treatment of glioblastoma (GBM) in the elderly remains unclear. The
impact of age on treatment planning, toxicity, and efficacy at a Canadian Cancer Centre was …

The incidence of glioblastoma in older adults has increased over the last few decades.
Current treatment includes surgery, radiotherapy, and chemotherapy, but optimal disease …

Median age at diagnosis in patients with glioblastoma (GB) is slowly increasing with an
aging population in Western countries, and was 64years in 2006. The number of patients …

Optimizing the management of elderly patients with glioblastoma is an ongoing task in neuro-
oncology. The number of patients with this tumor type is gradually increasing with the aging …